Pacific Biosciences of California has been granted a patent for engineered polymerases with modified motifs A and B, increasing accuracy in identifying bases in nucleic acids. The method involves forming a ternary complex with a fluorescently labeled test nucleotide, detecting the base, and incorporating the correct nucleotide. GlobalData’s report on Pacific Biosciences of California gives a 360-degree view of the company including its patenting strategy. Buy the report here.
Smarter leaders trust GlobalData
According to GlobalData’s company profile on Pacific Biosciences of California, Optoelectronic biosensors was a key innovation area identified from patents. Pacific Biosciences of California's grant share as of February 2024 was 56%. Grant share is based on the ratio of number of grants to total number of patents.